NCI | Technology Transfer

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

The Netherlands
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Italy
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Ireland
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

United Kingdom
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

France
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Spain
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Germany
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Belgium
15191395.1
Filed on 2015-10-26

Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Read more about Mutated Pseudomonas Exotoxins with Reduced Antigenicity

Austria
15191395.1
Filed on 2015-10-26

ANTI-MAGE-A3/A6 ANTIBODIES, POLYPEPTIDES, AND PROTEINS

Read more about ANTI-MAGE-A3/A6 ANTIBODIES, POLYPEPTIDES, AND PROTEINS

Patent Cooperation Treaty
PCT/US2017/060097
Filed on 2017-11-06

Subscribe to NCI